Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations

Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations Publisher

Asadi M¹ ; Fayazi F² ; Iraji A^{3, 4} ; Sabourian R⁵ ; Azizian H¹ ; Hajimahmoodi M⁵ ; Larijani B⁶ ; Mahdavi M⁶ ; Amanlou M^{2, 7}

Show Affiliations

1. Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Sciences, Tehran, Iran
2. Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
3. Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
4. Central Research Laboratory, Shiraz University of Medical Sciences, Shiraz, Iran
5. Drug and Food Control Department, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
6. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
7. Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: BMC Chemistry Published:2024

Abstract

A novel series of 4-nitrophenylpiperazine derivatives (4a–m) was designed and synthesized as potential tyrosinase inhibitors. Comprehensive characterization using 1H-NMR, 13C-NMR, CNH, and IR techniques was performed for all target compounds. Subsequently, the derivatives were evaluated for their inhibitory activity against tyrosinase. Among them, compound 4l, featuring an indole moiety at the N−1 position of the piperazine ring, exhibited a significant tyrosinase inhibitory effect with an IC50 value of 72.55 μM. Enzyme kinetics analysis revealed that 4l displayed mixed inhibition of the tyrosinase enzymatic reaction. Molecular docking was carried out in the enzyme’s active site to further investigate the enzyme-inhibitor interactions. Based on the findings, compound 4l shows promise as a lead structure for the design of potent tyrosinase inhibitors. This study paves the way for the development of more effective tyrosinase inhibitors for potential applications in various fields. © The Author(s) 2024.

Related Docs

View other Related Docs

1. Design, Synthesis, in Vitro, and in Silico Studies of Novel Benzylidene 6-Methoxy-1-Tetralone Linked to Benzyloxy and Benzyl -1,2,3- Triazole Rings As Potential Tyrosinase Inhibitors, Journal of Molecular Structure (2023)

2. Evaluating the Effects of Disubstituted 3-Hydroxy-1H-Pyrrol-2(5H)-One Analog As Novel Tyrosinase Inhibitors, Bioorganic Chemistry (2022)

3. Cinnamic Acid Conjugated With Triazole Acetamides As Anti-Alzheimer and Anti-Melanogenesis Candidates: An in Vitro and in Silico Study, Scientific Reports (2025)

4. Kinetic Studies, Molecular Docking, and Antioxidant Activity of Novel 1,3-Diphenyl Pyrazole-Thiosemicarbazone With Anti-Tyrosinase and Anti-Melanogenesis Properties, Bioorganic Chemistry (2024)

5. Thiazolopyrimidine Derivatives As Novel Class of Small Molecule Tyrosinase Inhibitor, BMC Chemistry (2023)

6. Rational Design, Synthesis, in Vitro, and in Silico Studies of Chlorophenylquinazolin-4(3H)-One Containing Different Aryl Acetohydrazides As Tyrosinase Inhibitors, Chemistry and Biodiversity (2022)

7. Synthesis, Biological Evaluation, and Molecular Docking Analysis of Novel 1, 3, 4-Thiadiazole -Based Kojic Acid Derivatives As Tyrosinase Inhibitors, Journal of Molecular Structure (2022)

8. Novel Morpholine Containing Cinnamoyl Amides As Potent Tyrosinase Inhibitors, International Journal of Biological Macromolecules (2019)

Experts (# of related papers)

View all Related Experts

Mohammad Mahdavi (10)

Bagher Larijani (6)

Style	Citing Format
MLA	Asadi M, et al.. "Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations." BMC Chemistry, vol. 18, no. 1, 2024, pp. -.
APA	Asadi M, Fayazi F, Iraji A, Sabourian R, Azizian H, Hajimahmoodi M, Larijani B, Mahdavi M, Amanlou M (2024). Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations. BMC Chemistry, 18(1), -.
Chicago	Asadi M, Fayazi F, Iraji A, Sabourian R, Azizian H, Hajimahmoodi M, Larijani B, Mahdavi M, Amanlou M. "Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations." BMC Chemistry 18, no. 1 (2024): -.
Harvard	Asadi M et al. (2024) 'Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations', BMC Chemistry, 18(1), pp. -.
Vancouver	Asadi M, Fayazi F, Iraji A, Sabourian R, Azizian H, Hajimahmoodi M, et al.. Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations. BMC Chemistry. 2024;18(1):-.
BibTex	@article{ author = {Asadi M and Fayazi F and Iraji A and Sabourian R and Azizian H and Hajimahmoodi M and Larijani B and Mahdavi M and Amanlou M}, title = {Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations}, journal = {BMC Chemistry}, volume = {18}, number = {1}, pages = {-}, year = {2024} }
RIS	TY - JOUR AU - Asadi M AU - Fayazi F AU - Iraji A AU - Sabourian R AU - Azizian H AU - Hajimahmoodi M AU - Larijani B AU - Mahdavi M AU - Amanlou M TI - Nitrophenylpiperazine Derivatives As Novel Tyrosinase Inhibitors: Design, Synthesis, and in Silico Evaluations JO - BMC Chemistry VL - 18 IS - 1 SP - EP - PY - 2024 ER -

Science Communicator Platform

Authors

Authors Affiliations

Abstract